RT Journal Article
SR Electronic
T1 Estimation of offspring genetic risk scores using parental genotypes
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.06.09.22276224
DO 10.1101/2022.06.09.22276224
A1 Adesomo, Adebayo
A1 Workalemahu, Tsegaselassie
A1 Givens, Matthew
A1 Yandell, Mark
A1 Quinlan, Aaron
A1 Tristani-Firouzi, Martin
A1 Heerboth, Sarah
A1 Silver, Robert
A1 Blue, Nathan
YR 2022
UL http://medrxiv.org/content/early/2022/06/14/2022.06.09.22276224.abstract
AB Objective Our objective was to determine whether genetic risk scores (GRSs) of offspring can be accurately estimated from parental DNA.Methods Whole genome sequencing data from a cohort of forty-seven multi-generation Utah families were used to extract single nucleotide polymorphism (SNP) data at genetic loci associated with the following traits: birth weight (BW), fasting plasma glucose (FPG), blood pressure (BP), body mass index (BMI), height, and type 2 diabetes (T2D). Offspring GRSs for each trait were estimated from parental single nucleotide polymorphism (SNP) data and compared to actual offspring GRSs. We also assessed offspring GRS estimation using only one parent’s DNA to simulate scenarios when only one genetic parent is available. The primary outcome was the percent error of parental-derived estimated GRS for each trait. An a priori threshold of 10% error was chosen for estimated GRSs to be considered accurate.Results Forty-three families with an average of 8.9 ± 1.8 offspring (N = 454 offspring) had parental and offspring SNP data available for GRS calculations. Mean percent errors for estimated offspring GRSs were less than 10% for all traits except for FPG (10.5% ± 8.1%). Percent errors were not significantly different when offspring GRSs were estimated using only one parent’s DNA whether the missing parent was a father or mother. Mean percent error of GRSs decreased exponentially with increasing SNPs per trait, with diminishing improvement in percent error above 500 SNPs.Conclusion Parental genetic risk scores can be used to accurately estimate genetic risk scores of offspring. This proof of concept supports further exploration of parental genetic risk scores as a tool for prenatal fetal genetic risk stratification.Statements What’s already known about this topic?Genetic risk scoring is a tool to estimate the probability of development traits or conditions with complex, multifactorial inheritance.What does this study add?Offspring genetic risk scores can be accurately estimated using parental DNA. This proof of concept supports further exploration of parental genetic risk scores as a tool for prenatal fetal genetic risk stratification.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the NICHD, award 2K12HD085816-07. Additionally, we would like to acknowledge gifts from the W.M. Keck Foundation (to Stephen M. Prescott and Mark F. Leppert) and from the George S. and Delores Dore Eccles Foundation (to the University of Utah), which supported the Utah Genetic Reference Project (UGRP). Sequencing of the CEPH samples was made possible by funding from by the Utah Genome Project, the George S. and Dolores Dore Eccles Foundation, and the H.A. and Edna Benning Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB of the University of Utah Health gave ethical approval for both the parent study and this secondary analysis.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWhole genome sequencing data for UGRP cohort participants are available in CRAM and VCF format via controlled access through the University of Utah Center for Genomic Medicine. Overview of available data and the application process are available at https://uofuhealth.utah.edu/center-genomic-medicine/research/ceph-resources.php.